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pletely beyond 100 days after the operation. The freedom
from surgical reintervention was very acceptable.
Resource Consumption
Different types of resources, both human and material, are
used in treating patients undergoing CABG in cardiogenic
shock and during CPR. The consequences of treating these
patients will differ considerably between health care eco-
nomic systems. In some countries these will be just addi-
tional charges, whereas in others these will be unrecover-
able costs. The most visible resource consumption, hospital
stay, was only doubled in these patients. This event was
once more influenced by the competing early hospital mor-
tality. A higher price was paid for the use of hemodialysis
and support devices. Some survivors with stroke have been
confronted with the medical and socioeconomic conse-
quences of this condition and the partly failed therapy.
Our departmental policy has changed to mandating an
immediate surgical approach consisting of initiation of ex-
tracorporeal circulation for all patients in cardiogenic shock
or receiving CPR and amendable by CABG. If the first
arterial pH is less than 6.9, we advise discontinuation of all
therapy and urge the caregiver to proceed with extreme
caution if the pH is less than 7.1. The use of additional
resources (dialysis, intermediary, and long-term mechanical
support) is weighed against the life expectancy (judged by
the presence and severity of comorbidity).
Patients undergoing CABG in cardiogenic shock and
during CPR have disrupted the surgical routine of coronary
surgery. They have induced an additional opportunistic re-
source cost.
The appropriate use of health care resources in a popu-
lation is a delicate balance between an individual patient’s
rights and the collective responsibility of the community.
This study suggests that health care purchasers should allow
and cover this approach. Clinicians should continue the
search for clinical discriminative markers guided but not
driven by available variables.
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Discussion
Dr Ludwig K. von Segesser (Lausanne, Switzerland). Given
the difficult set of patients analyzed, a hospital mortality rate of
35% and an almost 50% survival after 10 years of follow-up is
excellent. It comes as no surprise that early mortality is the main
cause of loss of life and that patients requiring CPR do less well
than patients with shock not requiring CPR.
Dr Sergeant, the observation period of this study is about 22
years, and therefore the mean number of patients operated on per
year for shock is about 8 and for CPR is about 4. It would be very
interesting for the audience to know whether the distribution over
time of the patients operated on is uniform. I am asking this
because in our own experience, like in yours, the main cause of
acute need of surgical intervention is an incident in the catheter-
ization laboratory, for example, a crashed percutaneous translumi-
nal coronary angioplasty. However, these events are unevenly
distributed over time and much less frequent nowadays. If you get
called in now for such patients, the myocardium has usually
suffered already for a couple of hours, and all sorts of drugs,
devices, and time have been wasted. Hence the patients we saw 20
years ago and those we see today are not exactly the same.
Furthermore, I would like to ask you to give us some insight in
the delays observed between the initial event and the decision to go
for surgical intervention, initiation of cardiopulmonary bypass, and
delay until reperfusion. Is there a correlation between the time
elapsed and outcome?
Dr Sergeant. Thank you, Professor von Segesser, for these
questions. The first question is the prevalence or the incidence of
these patients. Indeed, as you point out correctly, the prevalence is
around 12 patients a year. You are correct that the patient’s clinical
condition might have changed over time. This becomes obvious on
the basis of the importance of the biologic markers of “pH at entry
of the operating theater” versus the cause leading to the operation.
Concerning the delay between the events: we have a system
with 24-7 standby, basically on an around-the-clock basis. If our
support is called in, we can be in 15 minutes on extracorporeal
circulation around the clock. Therefore the delays are very short,
but as you point out, the cardiologists and all our colleagues from
different departments have spent a lot more time and energy in
treating these patients. We have tried to build inferences from the
chaotic clinical paths in all these different patients and bring this
down in a more structured form.
Dr von Segesser. I had one last question to the expert in
statistics you are. You write that a higher EuroSCORE is an
independent predictor of mortality; however, EuroSCORE is the
sum of semicontinuous and categoric variables having an arbitrary
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weight. Some are dependent of others, and some are not. How does
your mathematic model handle this problem?
Dr Sergeant. Your comment is a very interesting one. In a total
population of 259 patients, one cannot expect to obtain stable
coefficient for rare variables. This is the reason we have chosen to
use a composed variable, such as the EuroSCORE, to avoid this
limitation. I have discussed this element in the Discussion section
of the article.
Dr Charles Yankah (Berlin, Germany). Dr Sergeant, I would
like you to comment on the troponin levels, cardiac indices, SVO2,
and echocardiographic data on left ventricular wall thickness as
determinant risk factors for early death in your patients receiving
CPR before and after CABG. If you have those hemodynamic
parameters, the heart failure scores indicating persistent heart
failure within 12 to 24 hours after CABG, which are considered to
be incremental risk factors and predictors for early death, which
surgical-therapeutic concept would you advocate to improve the
outcome of those patients who are unresponsive to medical therapy
with intraortic counterpulsation?
Dr Sergeant. Of course these patients are very extensively
monitored and studied. Troponin or creatine kinase levels are very
dramatically influenced by the very early extended extracorporeal
circulation. In more than half of these patients, we have taken
electron microscopic biopsy specimens, and I can tell you that if
your analysis is very correct and your electron microscopic anal-
ysis is very correct, one will identify necrosis of myocardial cells
in nearly all of these patients. We have, of course, done ECG and
echocardiographic studies in these patients.
Some governments have decided to reimburse only one echo-
cardiograph over a whole year time frame, and these patients have,
of course, an echocardiogram at the time of diagnosis of the
disease during the operation and, in fact, every day in intensive
care for the next days.
Dr Fabrizio Follis (Palermo, Italy). In your series there was a
subset of patients who underwent redo procedures. In that case,
what were the results, and is there is any different policy in treating
redo patients?
Dr Sergeant. Late redo procedures have dramatic results. It
turned out that in the mathematic models, after correction for
variability, the effect of the redo situation was minimal and not any
more within the rules of significance.
Dr Jeremy R. Morton (Portland, Me). You mentioned that
you made fairly liberal use of the left ventricular assist device. I
have 2 quick questions. First, has your overall experience with
respect to survival in this class of patients improved over the
years? Second, has your experience with the left ventricular assist
device in these patients been sufficiently good for you to be
enthusiastic about its use?
Dr Sergeant. That is a very difficult question. We have a very
liberal use as well of rotary devices, as extracorporeal or intracor-
poreal devices. I tried to identify the effect of the date of the
operation as an incremental risk factor in the survival, and it was
not there. It could have been that the sample size was still too
small. We would have been very proud in showing an improved
survival now versus 10 years ago. We were not able to identify
that.
Dr D. Craig Miller (Stanford, Calif). Paul, I noticed your
oldest patient was 90 years old. It makes me wonder who you did
not try to salvage?
Dr Sergeant. I must say I did not treat all these patients. I
treated probably 70% of these. I do not always agree with every-
thing that happens when I am not there, but I can tell you that this
particular patient survived. The discriminatory power of a pivot
value of 90 years of age is so reduced. And I think your question
is very pertinent because I was upset when this patient had been
treated, but the analysis shows that the discriminatory power of age
is too low to predict. Therefore maybe we should indeed be
treating that patient who is 90 years of age with a good pH at entry
into the operating theater and maybe not a patient who is 40 years
of age with a pH of 6.7.
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